SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-016980
Filing Date
2019-03-25
Accepted
2019-03-25 08:02:27
Documents
5
Period of Report
2019-03-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-7133_38k.htm 8-K 34843
2 EX-1.1 a19-7133_3ex1d1.htm EX-1.1 106801
3 EX-5.1 a19-7133_3ex5d1.htm EX-5.1 13536
4 EX-10.1 a19-7133_3ex10d1.htm EX-10.1 212415
5 GRAPHIC g71333kki001.jpg GRAPHIC 2391
  Complete submission text file 0001104659-19-016980.txt   372340
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36714 | Film No.: 19701360
SIC: 2834 Pharmaceutical Preparations